Search research articles
Contact Us
Filters
Showing results (31-40 of 118) with videos related to
Page
of 12
Sort By:
Drugs
|
April 1, 1990
Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections
D Faulds, R C Heel
Drugs
|
May 1, 1997
Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice
H M Bryson, D Faulds
Drugs & Aging
|
September 18, 1998
Repaglinide
J A Balfour, D Faulds
Drugs
|
June 1, 1992
Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders
S M Grant, D Faulds
Drugs
|
January 29, 2000
Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients
L R Wiseman, D Faulds
Pharmacoeconomics
|
April 8, 1993
Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infections
J A Balfour, D Faulds
Drugs
|
September 1, 1994
Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders
C M Spencer, D Faulds
Drugs
|
June 1, 1995
Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy
C R Lee, D Faulds
Drugs
|
November 1, 1996
Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections
C M Perry, D Faulds
Drugs
|
March 1, 1997
Epirubicin. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of breast cancer
A J Coukell, D Faulds
Page
of 12
Search research articles
Search
Showing results (31-40 of 118) with videos related to
Sort By:
Page
of 12
Drugs
|
April 1, 1990
Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections
D Faulds, R C Heel
Drugs
|
May 1, 1997
Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice
H M Bryson, D Faulds
Drugs & Aging
|
September 18, 1998
Repaglinide
J A Balfour, D Faulds
Drugs
|
June 1, 1992
Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders
S M Grant, D Faulds
Drugs
|
January 29, 2000
Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients
L R Wiseman, D Faulds
Pharmacoeconomics
|
April 8, 1993
Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infections
J A Balfour, D Faulds
Drugs
|
September 1, 1994
Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders
C M Spencer, D Faulds
Drugs
|
June 1, 1995
Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy
C R Lee, D Faulds
Drugs
|
November 1, 1996
Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections
C M Perry, D Faulds
Drugs
|
March 1, 1997
Epirubicin. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of breast cancer
A J Coukell, D Faulds
Page
of 12